{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:19:41Z","timestamp":1770819581273,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06259-7","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:42:25Z","timestamp":1770817345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does perioperative chemotherapy affect renal function after radical nephroureterectomy for upper tract urothelial carcinoma?"],"prefix":"10.1007","volume":"44","author":[{"given":"Pierre-Etienne","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Seisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Culine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Desgrandchamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Masson-Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"3","key":"6259_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","volume":"35","author":"F Soria","year":"2017","unstructured":"Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W et al (2017) Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol Mars 35(3):379\u2013387","journal-title":"World J Urol Mars"},{"issue":"6","key":"6259_CR2","first-page":"1224","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 15 Mars 115(6):1224\u20131233","journal-title":"Cancer 15 Mars"},{"key":"6259_CR3","doi-asserted-by":"crossref","unstructured":"Masson-Lecomte A, Birtle A, Pradere B, Capoun O, Comp\u00e9rat E, Dom\u00ednguez-Escrig JL et al (2025) European association of urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update. Eur Urol 87(6):697\u20137167","DOI":"10.1016\/j.eururo.2025.02.023"},{"issue":"6","key":"6259_CR4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","volume":"98","author":"GA Brown","year":"2006","unstructured":"Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CPN, Swanson DA et al (2006) Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int d\u00e9c 98(6):1176\u20131180","journal-title":"BJU Int d\u00e9c"},{"key":"6259_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OTT.S225301","volume":"13","author":"JJ Leow","year":"2020","unstructured":"Leow JJ, Liu Z, Tan TW, Lee YM, Yeo EK, Chong YL (2020) Optimal management of upper tract urothelial carcinoma: current perspectives. OncoTargets Ther 13:1\u201315","journal-title":"OncoTargets Ther"},{"issue":"10232","key":"6259_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet Lond Engl 18 Avr 395(10232):1268\u20131277","journal-title":"Lancet Lond Engl 18 Avr"},{"issue":"4","key":"6259_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","volume":"58","author":"MG Kaag","year":"2010","unstructured":"Kaag MG, O\u2019Malley RL, O\u2019Malley P, Godoy G, Chen M, Smaldone MC et al (2010) Changes in renal function following nephroureterectomy May affect the use of perioperative chemotherapy. Eur Urol Oct 58(4):581\u2013587","journal-title":"Eur Urol Oct"},{"issue":"12","key":"6259_CR8","first-page":"2967","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 15 Juin 116(12):2967\u20132973","journal-title":"Cancer 15 Juin"},{"issue":"1","key":"6259_CR9","doi-asserted-by":"publisher","first-page":"31e17","DOI":"10.1016\/j.urolonc.2012.11.014","volume":"32","author":"FA Yafi","year":"2014","unstructured":"Yafi FA, Tanguay S, Rendon R, Jacobsen N, Fairey A, Izawa J et al (2014) Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome. Urol Oncol Janv 32(1):31e17\u201331e24","journal-title":"Urol Oncol Janv"},{"issue":"4","key":"6259_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.21037\/tau.2020.03.48","volume":"9","author":"MG Kaag","year":"2020","unstructured":"Kaag MG (2020) Perioperative chemotherapy in the management of high risk upper tract urothelial cancers. Transl Androl Urol ao\u00fbt 9(4):1881\u20131890","journal-title":"Transl Androl Urol ao\u00fbt"},{"issue":"1","key":"6259_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12894-022-01112-6","volume":"22","author":"JH Tae","year":"2022","unstructured":"Tae JH, Ha MS, Chi BH, Chang IH, Kim TH, Myung SC et al (2022) Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study. BMC Urol 9 Nov 22(1):175","journal-title":"BMC Urol 9 Nov"},{"key":"6259_CR12","doi-asserted-by":"crossref","unstructured":"Song W, Sung HH, Han DH, Jeong BC, Seo SI, Jeon SS et al (2017) The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer. Urol Oncol. mars. ;35(3):114.e1-114.e7","DOI":"10.1016\/j.urolonc.2016.10.022"},{"issue":"5","key":"6259_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","volume":"79","author":"JJ Leow","year":"2021","unstructured":"Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J (2021) Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: A 2020 systematic review and Meta-analysis, and future perspectives on systemic therapy. Eur Urol Mai 79(5):635\u2013654","journal-title":"Eur Urol Mai"},{"key":"6259_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/bs.acr.2021.03.008","volume":"152","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ye ZW, Tew KD, Townsend DM (2021) Cisplatin chemotherapy and renal function. Adv Cancer Res 152:305\u2013327","journal-title":"Adv Cancer Res"},{"issue":"1","key":"6259_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","volume":"31","author":"S Manohar","year":"2018","unstructured":"Manohar S, Leung N (2018) Cisplatin nephrotoxicity: a review of the literature. J Nephrol f\u00e9vr 31(1):15\u201325","journal-title":"J Nephrol f\u00e9vr"},{"issue":"5","key":"6259_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.ackd.2021.08.001","volume":"28","author":"S Gupta","year":"2021","unstructured":"Gupta S, Portales-Castillo I, Daher A, Kitchlu A (2021) Conventional chemotherapy nephrotoxicity. Adv Chronic Kidney Dis Sept 28(5):402\u2013414e1","journal-title":"Adv Chronic Kidney Dis Sept"},{"issue":"5","key":"6259_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/bju.12597","volume":"114","author":"M Kaag","year":"2014","unstructured":"Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF et al (2014) Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int Nov 114(5):674\u2013679","journal-title":"BJU Int Nov"},{"issue":"6","key":"6259_CR18","doi-asserted-by":"publisher","first-page":"268e1","DOI":"10.1016\/j.urolonc.2015.03.006","volume":"33","author":"N Singla","year":"2015","unstructured":"Singla N, Gayed BA, Bagrodia A, Krabbe LM, Palazzi KL, Mirheydar H et al (2015) Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma. Urol Oncol Juin 33(6):268e1\u2013268e7","journal-title":"Urol Oncol Juin"},{"issue":"4","key":"6259_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","volume":"112","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int ao\u00fbt 112(4):453\u2013461","journal-title":"BJU Int ao\u00fbt"},{"issue":"8\u20139","key":"6259_CR20","first-page":"446","volume":"33","author":"PE Gabriel","year":"2023","unstructured":"Gabriel PE, Lambert T, Dumont C, Gauthier H, Masson-Lecomte A, Culine S (2023) [Preoperative chemotherapy for patients with upper tract urothelial carcinoma: impact on renal function]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol ao\u00fbt 33(8\u20139):446\u2013455","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol ao\u00fbt"},{"issue":"Supplement 4","key":"6259_CR21","first-page":"e999","volume":"201","author":"A Coleman Jonathan","year":"2019","unstructured":"Coleman * Jonathan A, Wong NC, Sjoberg DD, Silva N, Bochner BH, Dalbagni G et al (2019) Lba-17 multicenter prospective phase Ii clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma. J Urol Avr 201(Supplement 4):e999\u2013e999","journal-title":"J Urol Avr"},{"issue":"3","key":"6259_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000187821","volume":"66","author":"AJ Verplanke","year":"1994","unstructured":"Verplanke AJ, Herber RF, de Wit R, Veenhof CH (1994) Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity. Nephron 66(3):267\u2013272","journal-title":"Nephron"},{"issue":"10","key":"6259_CR23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","volume":"104","author":"P Colin","year":"2009","unstructured":"Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int Nov 104(10):1436\u20131440","journal-title":"BJU Int Nov"},{"key":"6259_CR24","doi-asserted-by":"crossref","unstructured":"Yamada Y, Nakagawa T, Miyakawa J, Kawai T, Tabata M, Kaneko T et al (2021) Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study. Jpn J Clin Oncol 5(10):1577\u20131586","DOI":"10.1093\/jjco\/hyab081"},{"issue":"5","key":"6259_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.eururo.2018.07.029","volume":"74","author":"A Antonelli","year":"2018","unstructured":"Antonelli A, Minervini A, Sandri M, Bertini R, Bertolo R, Carini M et al (2018) Below safety Limits, every unit of glomerular filtration rate counts: assessing the relationship between renal function and Cancer-specific mortality in renal cell carcinoma. Eur Urol Nov 74(5):661\u2013667","journal-title":"Eur Urol Nov"},{"key":"6259_CR26","doi-asserted-by":"crossref","unstructured":"Gabriel PE, Pinar U, Lenfant L, Parra J, Vaessen C, Mozer P et al (2023) Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma. World J Urol 41(11):3001\u20133007","DOI":"10.1007\/s00345-023-04590-x"},{"issue":"11","key":"6259_CR27","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00345-022-04156-3","volume":"40","author":"A Tafuri","year":"2022","unstructured":"Tafuri A, Marchioni M, Cerrato C, Mari A, Tellini R, Odorizzi K et al (2022) Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical nephroureterectomy outcomes (RaNeO) research Consortium). World J Urol Nov 40(11):2771\u20132779","journal-title":"World J Urol Nov"},{"issue":"2","key":"6259_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000353652","volume":"92","author":"O Rodr\u00edguez Faba","year":"2014","unstructured":"Rodr\u00edguez Faba O, Palou J, Breda A, Maroto P, Fern\u00e1ndez G\u00f3mez JM, Wong A et al (2014) Predictive factors for impaired renal function following nephroureterectomy in upper urinary tract urothelial cell carcinoma. Urol Int 92(2):169\u2013173","journal-title":"Urol Int"},{"issue":"11","key":"6259_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/jjco\/hyv136","volume":"45","author":"T Hashimoto","year":"2015","unstructured":"Hashimoto T, Ohno Y, Nakashima J, Gondo T, Nakagami Y, Namiki K et al (2015) Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Jpn J Clin Oncol Nov 45(11):1064\u20131068","journal-title":"Jpn J Clin Oncol Nov"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06259-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:42:29Z","timestamp":1770817349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06259-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6259"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06259-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this study, oral consent was obtained for every patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"160"}}